Loxoprofen sodium/methocarbamol

Drug Profile

Loxoprofen sodium/methocarbamol

Alternative Names: IP-TN; Loxoprofen/methocarbamol

Latest Information Update: 06 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Boehringer Ingelheim
  • Class Analgesics; Muscle relaxants; Nonsteroidal anti-inflammatories
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Pain

Most Recent Events

  • 01 Oct 2016 Boehringer Ingelheim completes a phase III trial in Pain in Japan (NCT02831569)
  • 27 Jul 2016 Chemical structure information added
  • 11 Jul 2016 Boehringer Ingelheim plans a phase III trial for Pain (In adolescents, In adults, In the elderly) in Japan (NCT02831569)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top